US Bancorp DE Has $33.94 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

US Bancorp DE cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 65,016 shares of the medical equipment provider’s stock after selling 2,427 shares during the quarter. US Bancorp DE’s holdings in Intuitive Surgical were worth $33,936,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Massachusetts Financial Services Co. MA bought a new stake in shares of Intuitive Surgical in the third quarter valued at about $558,807,000. Proficio Capital Partners LLC grew its stake in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after buying an additional 948,902 shares in the last quarter. FMR LLC increased its stake in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB increased its position in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares during the last quarter. Finally, Strategic Financial Concepts LLC raised its stake in Intuitive Surgical by 50,740.8% in the 4th quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock valued at $163,202,000 after acquiring an additional 312,056 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $573.15 on Friday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a market capitalization of $204.14 billion, a price-to-earnings ratio of 89.42, a PEG ratio of 5.85 and a beta of 1.39. The stock’s 50 day moving average price is $569.87 and its two-hundred day moving average price is $529.06.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research analyst reports. Truist Financial increased their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Raymond James upped their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Royal Bank of Canada raised their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Leerink Partners lifted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $613.10.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 8,077 shares of company stock valued at $4,620,025 in the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.